Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a25b0799ced3ee32

Jump to content

// Workers AI · dad joke modeWhat did Recherche et Industrie Thérapeutiques say to the pill? "You're a cure-ious friend

From Wikipedia, the free encyclopedia
(Redirected from SmithKline-RIT)

Recherche et Industrie Thérapeutiques
Founded1945; 81 years ago (1945) in Genval, Belgium
FounderPieter De Somer
FateMerged with Glaxo and SmithKline to form GlaxoSmithKline
Key people
Roger Connor, CEO

Recherche et Industrie Thérapeutiques (R.I.T.) was founded in Genval, Belgium, as a penicillin factory in 1945 by Dr Pieter De Somer, who later became the founder of the Rega Institute for Medical Research and rector of the Katholieke Universiteit Leuven (Leuven, Belgium). The industrialist Jean Lannoye provided the funding for the company. The company started its vaccine research and production in the 1950s. The present CEO of the company is Roger Connor.

In 1968, the company was acquired by Smith, Kline & French and the name was changed to SmithKline-RIT. In 1989, it became SmithKline Beecham Biologicals, and since 2000 GlaxoSmithKline Biologicals.

History

[edit]

In 1945, the company was founded under the name of R.I.T. in Genval. In 1956, they began the production of vaccines for (polio vaccine). In 1958, the company acquired a site in Rixensart. In 1968, R.I.T. became a subsidiary company of SmithKline Corp. In 1989, there was a merger between SmithKline and Beecham.

In 1992, R.I.T. acquired SSW-Dresden in Germany.[citation needed] 1995 saw the extension of the site in Rixensart towards two new sites in Belgium: Wavre for production and Gembloux for scaling-up. In 1995, an agreement was made on a joint venture in China. A joint venture in Russia followed in 1997.[citation needed]

In 2000, there was a merger between GlaxoWellcome and SmithKlineBeecham to form GlaxoSmithKline.[1]

See also

[edit]

References

[edit]
  1. Petersen, Andrew Ross Sorkin With Melody (17 January 2000). "Glaxo and SmithKline Agree To Form Largest Drugmaker". The New York Times. ISSN 0362-4331. Retrieved 25 June 2020.
[edit]